Evidence map›Paper›PMID 40261411›Full record

ArticleApplied microbiology and biotechnology2025

Development of a highly efficient base editing system for Lactobacilli to improve probiotics and dissect essential functions.

Hitoshi Mitsunobu, Yudai Kita, Yumiko Nambu-Nishida, Shoko Miyazaki, Kensuke Nakajima, Ken-Ichiro Taoka, Akihiko Kondo, Keiji Nishida

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Utilizing natural competence to genetically manipulateApplied and environmental microbiology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hitoshi Mitsunobu *Engineering Biology Research Center, Kobe University, Kobe, Hyogo, Japan.
Yudai Kita *Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.
Yumiko Nambu-NishidaBio Palette Co, Ltd, Kobe, Hyogo, Japan.
Shoko MiyazakiBio Palette Co, Ltd, Kobe, Hyogo, Japan.
Kensuke NakajimaBio Palette Co, Ltd, Kobe, Hyogo, Japan.
Ken-Ichiro TaokaEngineering Biology Research Center, Kobe University, Kobe, Hyogo, Japan.
Akihiko KondoEngineering Biology Research Center, Kobe University, Kobe, Hyogo, Japan.
Keiji NishidaEngineering Biology Research Center, Kobe University, Kobe, Hyogo, Japan. keiji_nishida@people.kobe-u.ac.jp.

Funding

GteX Program, JST, Japan JPMJGX23B4Japan Agency for Medical Research and Development 21ek0109448h0002Program on Open Innovation Platform with Enterprises, Research Institute and Academia JPMJOP1851
6 · The paper itself

Abstract

Lactobacilli play essential roles in the food industry and have a significant potential as probiotics and therapeutic agents. Genomic and genetic information has increasingly accumulated and been linked to their various functions, to which transgenic approaches are being performed to verify crucial genes. In order to reasonably develop more useful strains, beneficial traits need to be introduced into any given strains and enhanced or combined based on such genotype characterization. However, for practical use as probiotics or foods, organisms with transgene are hardly acceptable. Here, we have introduced the base editing Target-AID system specifically for Lactobacilli, enabling precise installation of point mutations without donor DNA and at multiple genomic loci simultaneously. Lactiplantibacillus plantarum has been successfully engineered to reduce production of imidazole propionate, which has been reported to be associated with type 2 diabetes by impairing glucose tolerance and insulin signaling. Additionally, this system enabled transient knock-out of an essential gene, such as one involved in cell division, resulting in severe filamentous cell phenotype. This demonstrates Target-AID is a promising genetic tool for Lactobacilli and can accelerate both applied and fundamental research. KEY POINTS: • Efficient and multiplexable cytosine base editing established in Lactobacilli. • Edited Lactobacillus reducing imidazole propionate associated with the risk of type 2 diabetes. • Transient knock-out and dissection of an essential gene function.

Indexed as

Gene EditingLactiplantibacillus plantarumLactobacillusProbioticsDiabetes Mellitus, Type 2Gene Knockout TechniquesGenes, EssentialImidazolesPoint MutationPropionatesImidazolesPropionatesCRISPRGenome editingImidazole propionateLactobacilliTarget-AIDurdA

Identifiers

PMID40261411
PMCPMC12014835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.